NCT06269640View on ClinicalTrials.gov

NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2027

Conditions
Hypertrophic CardiomyopathyLeft Ventricular Septal HypertrophyMitral Valve DiseaseAortic Valve Stenosis
Interventions
DEVICE

Septal Scoring Along Midline Endocardium

Transcatheter ventricular myotomy called SEptal Scoring Along the Midline Endocardium (SESAME) that relies on intramyocardial guidewire navigation and transcatheter electrosurgery

Trial Locations (2)

11576

RECRUITING

St Francis Hospital and Heart Center, Roslyn

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH